Hypoperfusion of the visual pathway in parkinsonian patients with visual hallucinations

Movement Disorders

Volumn 21, Issue 12, 2006, Pages 2140-2144

  Matsui, Hideaki ^a   Nishinaka, Kazuto ^a   Oda, Masaya ^a   Hara, Narihiro ^a   Komatsu, Kenichi ^a   Kubori, Tamotsu ^a   Udaka, Fukashi ^a  

^a SUMITOMO HOSPITAL   (Japan)

Author keywords

Parkinson's disease; Single photon emission computed tomography; Visual hallucination; Visual pathway

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; IOFETAMINE I 123; LEVODOPA; PERGOLIDE; PRAMIPEXOLE;

AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; OCCIPITAL CORTEX; PARIETAL LOBE; PARKINSON DISEASE; PATIENT SELECTION; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE; VISUAL HALLUCINATION; VISUAL SYSTEM;

AGED; BRAIN MAPPING; FUNCTIONAL LATERALITY; HALLUCINATIONS; HUMANS; IMAGING, THREE-DIMENSIONAL; IOFETAMINE; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; PARKINSONIAN DISORDERS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VISUAL PATHWAYS;

EID: 33846421581     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21140     Document Type: Article

References (27)

1. Saint-Cyr JA, Taylor AE, Lang AE. Neuropsychological and psychiatric side effects in the treatment of Parkinson's disease. Neurology 1993;43(Suppl. 6):S47-S52.
2. Yamamoto M. Parkinson's disease: cognitive and psychiatric aspects. Tokyo: Chugai Igakusha 2003 (in Japanese).
3. Sanchez-Ramos JR, Ortoll R, Paulson GW. Visual hallucinations associated with Parkinson's disease. Arch Neurol 1996;53:1265-1268.
4. Graham JM, Grunewald RA, Sagar HJ. Hallucinosis in idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1997;63:434-440.
5. Pappert EJ, Goetz CG, Niederman FG, Raman R, Leurgans S. Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease. Mov Disord 1999;14:117-121.
6. Factor SA, Molho ES, Podskalny GD, Brown D. Parkinson's disease: drug-induced psychiatric states. Adv Neurol 1995;65:115-138.
7. Banerjee AK, Falkai PG, Savidge M. Visual hallucinations in the elderly associated with the use of levodopa. Postgrad Med J 1989;65:358-361.
8. Fenelon G, Mahieux. F, Huon R, Ziegler M. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain 2000;123:733-745.
9. Shergill SS, Alker Z, Le Katona C. A preliminary investigation of laterality in Parkinson's disease and susceptibility to psychosis. J Neurol Neurosurg Psychiatry 1998;65:610-611.
10. de Ajuriaguerra J. Etude psychopathologique des parkinsoniens. In: de Ajuriaguerra J, Gauthier G, editors. Monoamines, Noyaux Gris Centraux et Syndrome de Parkinson. Geneve: Masson; 1971. p 327-355.
11. Tanner CM, Vogel C, Goetz CG, et al. Hallucinations in Parkinson's disease: a population study. Ann Neurol 1983;14:136.
12. Manford M, Andermarm F. Complex visual hallucinations. Clinical and neurobiological insights. Brain 1998;121:1819-1840.
13. Cogan DG. Visual hallucinations as release phenomena. Graefes Arch Clin Exp Ophthalmol 1973;188:139-150.
14. Butter T, Kuhn W, Muller T, et al. Visual hallucinations: the major clinical determinant of distorted chromatic contour perception in Parkinson's disease. J Neural Transm 1996;103:1195-1204.
15. Diederich NJ, Goetz CG, Raman R, Pappert EJ, Leurgans S, Piery V. Poor visual discrimination and visual hallucinations in Parkinson's disease. Clin Neuropharmacol 1998;21:289-295.
16. Diederich NJ, Goetz CG, Stebbins GT. Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model. Mov Disord 2005;20:130-140.
17. Matsui H, Udaka F, Tamura A, et al. The relation between visual hallucinations and visual evoked potential in Parkinson's disease. Clin Neuropharmacol 2005;28:79-82.
18. Friston KJ. Analyzing brain images: principles and overview. In: Frackowiak RSJ, Friston KJ, Frith CD, Dolan RJ, Mazziotta JC, editors. Human Brain Function. San Diego: Academic Press; 1997. p 25-41.
19. Oishi N, Udaka F, Kameyama M, Sawamoto N, Hashikawa K, Fukuyama H. Regional cerebral blood flow in Parkinson's disease with nonpsychotic visual hallucinations. Neurology 2005;65: 1708-1715.
20. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995;36:1238-1248.
21. Vertesi A, Lever JA, Molloy DW, et al. Standardized Mini-Mental State Examination. Use and interpretation. Can Fam Physician 2001;47:2018-2023.
22. Braak H, Rub U, Jansen Steur EN, Del Tredici K, de Vos RA. Cognitive status correlates with neuropathologic stage in Parkinson's disease. Neurology 2005;64:1404-1410.
23. Hughes AJ, Daniel SE, Kilford L, Lees AL Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
24. Holroyd S, Currie L, Wooten GF. Prospective study of ballucinations and delusions in Parkinson's disease. J Neurol Neurosurg Psychiatry 2001;70:734-738.
25. Wurtz RH, Kandel ER. Perception of motion, depth and form. In: Kandel ER, Schwartz JH, Jessell TM, editors. Principles of Neural Science. 4th ed. New York: McGraw-Hill; 2000. p 548-569.
26. Silva MF, Faria P, Regateiro FS, et al. Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease. Brain 2005;128:2260-2271.
27. Stebbins GT, Goetz CG, Carrillo MC, et al. Altered cortical visual processing in PD with hallucinations: an fMRI study. Neurology 2004;63:1409-1416.